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Purpose of review  
Advances in technology coupled with increased penetration of mobile phones and smart 
devices is rapidly changing health care delivery. Mobile phone applications (‘apps’), text 
messages, Internet platforms used alone or in combination are now providing interventions 
targeting people with multiple cardiovascular risk factors. This article will review the 
emerging evidence of apps and discuss the future of secondary prevention via mobile 
phones.  
Recent findings   
Seven recent randomised controlled trials used text messages or apps for six to 12 months, 
with or without differing combinations of other technology platforms. All studies 
demonstrated at least one positive improvement to cardiovascular risk factors measured in 
cardiac and diabetes populations. When measured, acceptability of the intervention was 
high.  
Summary  
Mobile apps and technology can deliver positive outcomes for managing cardiovascular risk 
factors. However, due to the complexity of combination interventions, it is difficult to 
determine the active ingredient. A future challenge for researchers and clinicians will be 
responding quickly to these rapidly evolving interventions to ensure the delivery of effective 
outcomes that are evidence-based.  
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Cardiac rehabilitation and secondary prevention programmes are recommended in 
international guidelines for people recovering from a cardiac event [1]. These programmes 
aim to reduce multiple cardiovascular disease (CVD) risk factors, and ensure uptake of 
cardioprotective medications. They have been demonstrated to reduce morbidity and 
mortality from CVD [2]. However, such programmes are typically delivered in an out-patient 
setting, with group-based exercise, and are time-limited [3]. Globally, reported participation 
rates are low, with the majority of cardiac event survivors failing to meet key CVD risk 
reduction targets [4]. Many barriers exist to referral, uptake, and completion, which have 
been widely documented [5]. Amongst the barriers, distance, timing of programmes, and 
unwillingness to participate in a group, are frequently cited [5]. With the rapid increase in 
mobile phone ownership, mobile phone enabled programmes are suggested as one way to 
address these barriers. 
Mobile applications or ‘apps’ are computer programs which operate on a smartphone, 
tablet, or other mobile device. They have a wide range of intended uses, from service 
provision, such as banking apps and travel booking, to social media and games. Mobile apps 
have become so commonplace in cardiovascular health that both the European Society of 
Cardiology and the American Heart Association have recently released position papers on 
their use [6, 7]. Both organisations comment on the great potential of mobile apps to 
transform cardiovascular health, but urge caution about the quality of widely available apps. 
This is not surprising, given the rapid development of apps. From June 2015 to January 2017 
the number of available apps in Apple’s app store alone rose from 1.5 million to 2.2 million 
[8]. The largest app store, Google Play, has over 2.5 million apps available [9]. 
Research involving apps has been considerably slower to evolve, and the majority of trials 
test a mobile phone based intervention aimed at improving a single risk factor, e.g. weight 
loss. However, there is emerging evidence that mobile apps can increase uptake and 
improve multiple CVD risk factors for people with CVD. Overall, seven studies have 
published results of randomised controlled trials (RCT) of mobile phone apps which provide 
multiple CVD risk factor reduction (Table 1) [10-15]. These studies were published between 
2012-2016 and used a variety of interventions from text messaging to combinations of 
mobile apps, text messages, and Internet pages.  
 
Studies delivering interventions via mobile phone 
The simplest mobile phone based interventions are text messages. Although several studies 
have used text messages as part of the intervention, only one study, the Tobacco, Exercise 
and Diet Messages RCT (TEXT-ME) has investigated text messaging without other 
components (e.g. supportive website) [11]. This single-blind, parallel group study recruited 
710 participants who had either had a myocardial infarction, or had coronary heart disease 
confirmed on angiogram. The participants were mostly male (82%), and mean age was 
58±9.2 years. Both groups participated in usual care, which included community follow up, 
and the majority were referred to cardiac rehabilitation. In addition, those in the 
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intervention group (n=352) received text messages four times a week for six months. The 
messages had been developed and tested to give simple, positive healthy information 
around key CVD risk reduction behaviours and medication adherence [16]. The messages 
were automated and tailored to the individuals’ baseline characteristics; for example, non-
smokers did not receive smoking cessation messages. The programme was not interactive. 
At six months, the primary endpoint of low density lipoprotein was 76mg/dl in the 
intervention group, compared to 84mg/dl in the usual care group, a mean difference of 
8mg/dl, which was statistically significant (p=0.04). Importantly, there were improvements 
in multiple CV risk factors in the intervention group. There were some interesting 
observations about the study from the qualitative evaluation. Firstly, although all 
participants were advised that the system was automated and one-directional, 403 text 
messages were received by the investigators from 116 unique mobile phone numbers [17]. 
It also appeared that when participants received the text messages they imagined that the 
research assistant who had recruited them was sending the messages personally. 
Importantly, the majority of the participants found the intervention acceptable, and many 
would have liked the intervention to continue past the six months of the study [17]. 
The other six studies used a combination of an Internet platform and either text messages, 
or biometric monitoring, or a mobile app. Using multiple elements makes it challenging to 
unpick which of these elements are the primary driver of behaviour change. The study by 
Blasco et al [10] was a single-blind RCT of 203 acute coronary syndrome survivors. Both 
groups received lifestyle counselling and the usual care of their treating physician. Those in 
the intervention group uploaded their weight, heart rate, blood pressure, lipids and glucose 
via their mobile phone, which were sent to a web interface. A cardiologist reviewed the data 
in the web interface, and made tailored recommendations, which were sent by text 
message. At 12 months, the intervention group, compared to the control group, had better 
achievement of treatment goals for blood pressure (62.1% vs 42.9%, p=0.012), and glycated 
haemoglobin A1c (86.4% vs 54.2%, p=0.018). They also had lower body mass index (-
0.77kg/m2 vs +0.29 kg/m2), p=0.005). However, there were no differences in low density 
lipoprotein levels or smoking cessation [10]. 
Another study that involved a monitoring health professional, delivering an intervention via 
a mobile phone was conducted in Finland by Karhula at al [18]. This study randomised 267 
participants with coronary heart disease, and 250 participants with diabetes to a self-
monitoring intervention, where the participants were asked to upload blood glucose, blood 
pressure, weight and steps to a mobile phone, which then automatically transferred the 
data to the patient’s personal health record. The health professional then called the 
participant on the mobile phone every 4-6 weeks to discuss the information that had been 
uploaded. The primary endpoint of the study was health related quality of life, however no 
difference in outcome was observed in either group. There were observed differences in the 
waist circumference between the coronary heart disease groups, and the diabetes groups, 
which led the authors to conclude that the intervention may work differently and be of 
more benefit to participants with diabetes [18]. However, although the intervention is 
described as a mobile phone intervention and appears to include text messaging, the text 
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messages went to the health care professional, so the primary potential for the intervention 
to promote behaviour change was really through 4-6 weekly telephone calls. 
The SUPPORT study [12] focused on increasing adherence to an anti-platelet drug, but also 
aimed to affect multiple cardiovascular risk factors in 174 individuals after a myocardial 
infarction. Both intervention and control groups received cardiac rehabilitation, as per the 
Swedish national standard. Both groups were also provided with a drug adherence diary app 
on their smartphone, which allowed the participants to record their intake of the anti-
platelet drug, and both groups were sent a text message reminder if they did not record 
taking the drug within the prescribed timeframe. In addition, the intervention group 
received educational messages within the app, tailored to their individual record. Within the 
apps, the intervention group could access four educational modules, including extended 
drug adherence, exercise, weight management and smoking cessation. An automated 
feedback logic was developed to ensure the messages were tailored, but the data that 
patients recorded was not monitored. When a message was generated in the app, a text 
message was also sent to alert the participant. At six months, the intervention group 
achieved greater medication adherence, compared to the control group (non- adherence 
score 16.6 vs 22.8, p=0.025) [12]. 
The HEART (Heart Exercise And Remote Technologies) study [15] involved a personalized, 
automated package of text messages and a secure internet site. This site included video 
messages aimed at increasing exercise behaviour, delivered over 24 weeks. Participants 
with coronary heart disease (n=171) were randomised to usual care, or the HEART 
intervention. The primary outcome was peak oxygen uptake (PVO2). At 24 weeks there were 
no differences in PVO2 between the two groups (difference −0.21 ml kg−1 min−1, 95% CI: 
−1.1, 0.7; p = 0.65). However, there were significant improvements in outcomes, including 
leisure time physical activity (difference 110.2 min/week, 95% CI: −0.8, 221.3; p = 0.05) and 
walking (difference 151.4 min/week, 95% CI: 27.6, 275.2; p = 0.02).  
Similarly, The Text4Heart study [13], which was conducted by the same investigators as the 
HEART study, also included daily text messages and a supporting website over a 24-week 
period. The messages were fully automated and underpinned by social cognitive theory. The 
trial included 123 participants with coronary heart disease, randomised to usual care, or the 
intervention group. The primary outcome was adherence to healthy lifestyle behaviors 
measured using a self-reported composite health behavior score (≥3) at 3 and 6 months. A 
significant treatment effect in favor of the intervention was observed for the primary 
outcome at 3 months (AOR 2.55, 95% CI 1.12-5.84; P=.03), but not at 6 months (AOR 1.93, 
95% CI 0.83-4.53; P=.13). Of note, 85% of people reported reading all the text messages 
they were sent, while visits to the supporting website varied from 0 to 100 per individual 
[13]. 
The final study is the Care Assessment Platform [14]. This was a randomised controlled trial 
of traditional cardiac rehabilitation compared to an intervention group using a smartphone 
cardiac rehabilitation app providing daily SMS messages, multimedia education topics, 
relaxation audio files, and a light to moderate physical activity program. Participants were 
able to set and monitor goals and the app included a step counter and exercise diary. Trial 
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results demonstrated uptake of cardiac rehabilitation was much higher in the intervention 
group. Importantly, the intervention group had significantly higher adherence and 
completion than the traditional cardiac rehabilitation group. Both the intervention group 
and traditional cardiac rehabilitation group significantly improved their 6-minute walk test 
distance (537±86–584±99 m vs 510±77–570±80 m), emotional state, and quality of life; and 
lost non-significant amounts of weight. The study demonstrated a smartphone app can 
achieve equivalent improvements in secondary prevention outcomes as traditional cardiac 
rehabilitation, and importantly had significantly higher uptake (80% vs 62%), adherence 
(94% vs 68%) and completion (80% vs 47%) rates than a traditional cardiac rehabilitation 
group (p<0.05). 
The future of secondary prevention via mobile phones 
The complexity of these interventions makes identifying the active ingredient and 
appropriate dose challenging. Mixed methods study design, and process evaluations will 
help to improve understanding of what really matters. Even in the TEXT-ME study, where 
the intervention appeared to be a simple one-directional text message, the qualitative 
component revealed that people tend to assign human characteristics to the intervention, 
believing that the automated messages were sent by the friendly research assistant who 
had recruited them [17]. 
As technology evolves this understanding will become ever more important. Wearable 
trackers that monitor physical activity have been shown to provide valid and reliable 
information for people with coronary heart disease [19]. To extend this further, the Internet 
of Things-where connected devices talk to each other to inform health care decisions- may 
become the secondary prevention tools of the future. An individual might have sensors at 
home or in the car that detect changes in heart rate or breathing, or subtle changes in skin 
colour that suggest need for a change in medication, or a reminder to take medication. 
Common digital assistants such as Apple’s Siri could be adapted for health purposes so that 
an algorithm prompts correct choices in health behaviours. Our biggest challenge as 
researchers and clinicians will be responding quickly enough to ensure that the evolving 
technologies are evidence-based and that we understand the benefits, or lack thereof, of 
the tools that are available. 
 
CONCLUSION  
Evidence for mobile phone delivered secondary prevention is emerging, and of seven RCT’s, 
six show improvements in cardiovascular risk factors, when compared to control. However, 
the diversity of the interventions makes it challenging to understand which ingredient 
matters most when it comes to recommending mobile phone interventions. In addition, 
long term outcomes are currently unknown.  As there are a multitude of apps currently 
available, it is also important that consumers can make informed choices.  The evidence-
base for the apps needs to be robust, credible, clear and unambiguous. Health-care bodies 
could regulate CVD apps or organisations such as heart foundations could provide 
endorsement for them., but volume of available apps makes this challenging. It may be 
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more feasible to provide consumers with tools to make informed decisions around choosing 
evidence-based apps that provide the best outcomes than to try to accredit individual apps. 
• There is emerging evidence that mobile phones interventions improve CVD risk 
factors 
• It is hard to determine the ‘active ingredient’ of mobile apps 
• The long term benefit of m-health is unknown 
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**Chow et al TEXT ME was a large RCT with a simple intervention which had significant impact of 
CVD risk factors. This paper is particularly notable for the simplicity of the intervention, it’s potential 
scalability and generalisability. 
*Redfern et al produced interesting insights into the mechanisms and context of the TEXT ME RCT 
and begins to explain some of the reasons this trial may have been successful. 
*Varnfield et al undertook the world first mobile app in CVD risk factor reduction. It is most notable 
for the increased participation and completion rates in the group that undertook the mobile 
intervention. 
